AFT Pharmaceuticals Limited (AFP.AX)
AUD 2.45
(0.0%)
AUD 2.45
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 194.03 Million | 156.64 Million | 130.31 Million | 113.1 Million | 105.59 Million | 85.12 Million |
| Cost of Revenue | 107.13 Million | 83.65 Million | 68.53 Million | 64.36 Million | 57.33 Million | 44.39 Million |
| Gross Profit | 86.89 Million | 72.98 Million | 61.77 Million | 48.74 Million | 48.26 Million | 40.73 Million |
| Operating Expenses | 62.63 Million | 54.32 Million | 40.65 Million | 37.41 Million | 28.45 Million | 37.63 Million |
| Selling, General and Administrative Expenses | 56.47 Million | 49.4 Million | 37.99 Million | 36.68 Million | 37.29 Million | 35.41 Million |
| Research and Development Expenses | 8.09 Million | 6.44 Million | 5.55 Million | 3.47 Million | 2.02 Million | 2.58 Million |
| Other Expenses | - | -189 Thousand | 1.43 Million | 1.24 Million | 10.31 Million | 2.49 Million |
| Cost and Expenses | 169.77 Million | 137.98 Million | 109.19 Million | 101.78 Million | 85.78 Million | 82.03 Million |
| Operating Income | 24.23 Million | 19.66 Million | 20.38 Million | 10.7 Million | 11.5 Million | 6.63 Million |
| Interest Expense | 3.68 Million | 2.87 Million | 2.43 Million | 3.44 Million | 8.05 Million | 8.41 Million |
| Income Tax Expense | 6.41 Million | 5.14 Million | 1.16 Million | 105 Thousand | 185 Thousand | 168 Thousand |
| Earnings before Tax | 22.01 Million | 15.79 Million | 18.68 Million | 7.88 Million | 12.87 Million | -2.25 Million |
| Net Income | 15.6 Million | 10.65 Million | 19.84 Million | 7.78 Million | 12.69 Million | -3.36 Million |
| Earnings Per Share Basic | 0.15 | 0.10 | 0.19 | 0.07 | 0.12 | -0.03 |
| Earnings Per Share Diluted | 0.15 | 0.10 | 0.19 | 0.07 | 0.12 | -0.03 |
| Weighted Average Shares Outstanding | 104.86 Million | 104.86 Million | 104.86 Million | 104.86 Million | 104.86 Million | 104.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.86 Million | 104.86 Million | 104.86 Million | 104.86 Million | 104.86 Million | 104.86 Million |
| Gross Margin | 0.45 | 0.47 | 0.47 | 0.43 | 0.46 | 0.48 |
| EBIT Margin | 0.14 | 0.13 | 0.16 | 0.10 | 0.11 | 0.08 |
| Profit Margin | 0.08 | 0.07 | 0.15 | 0.07 | 0.12 | -0.04 |
| EBITDA | 27.71 Million | 20.39 Million | 22.16 Million | 12.43 Million | 11.76 Million | 6.47 Million |
| Earnings Before Tax Margin | 0.12 | 0.13 | 0.16 | 0.09 | 0.11 | 0.08 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 194.03 Million | 111.79 Million | 83.61 Million | 156.64 Million | 90.89 Million | 65.75 Million |
| Cost of Revenue | 107.13 Million | 59.46 Million | 47.67 Million | 83.65 Million | 46.58 Million | 37.07 Million |
| Gross Profit | 86.89 Million | 52.33 Million | 35.93 Million | 72.98 Million | 44.3 Million | 28.67 Million |
| Operating Expenses | 66.57 Million | 30.44 Million | 32.18 Million | 54.32 Million | 29.16 Million | 25.16 Million |
| Selling, General and Administrative Expenses | - | 28.82 Million | 29.26 Million | - | 26.96 Million | 22.43 Million |
| Research and Development Expenses | - | 5.32 Million | 3.5 Million | - | 3.66 Million | 2.78 Million |
| Other Expenses | 3.3 Million | - | - | -189 Thousand | - | - |
| Cost and Expenses | 169.7 Million | 89.91 Million | 79.86 Million | 137.98 Million | 75.74 Million | 62.23 Million |
| Operating Income | 24.23 Million | 20.98 Million | 3.25 Million | 19.66 Million | 16.21 Million | 3.45 Million |
| Interest Expense | 3.68 Million | - | - | 2.87 Million | - | - |
| Income Tax Expense | 6.41 Million | 6.25 Million | 152 Thousand | 5.14 Million | 4.56 Million | 576 Thousand |
| Earnings before Tax | 22.01 Million | 20.05 Million | 1.96 Million | 15.79 Million | 13.67 Million | 2.12 Million |
| Net Income | 15.6 Million | 13.79 Million | 1.81 Million | 10.65 Million | 9.1 Million | 1.54 Million |
| Earnings Per Share Basic | - | 0.12 | 0.02 | - | 0.09 | 0.01 |
| Earnings Per Share Diluted | - | 0.12 | 0.02 | - | 0.09 | 0.01 |
| Weighted Average Shares Outstanding | 104.86 Million | 118.93 Million | 104.86 Million | 104.86 Million | 104.86 Million | 154.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.86 Million | 118.93 Million | 104.86 Million | 104.86 Million | 104.86 Million | 154.6 Million |
| Gross Margin | 0.45 | 0.47 | 0.43 | 0.47 | 0.49 | 0.44 |
| EBIT Margin | - | 0.19 | 0.04 | - | 0.17 | 0.06 |
| Profit Margin | 0.08 | 0.12 | 0.02 | 0.07 | 0.10 | 0.02 |
| EBITDA | - | 20.89 Million | 3.73 Million | - | 15.74 Million | 4.13 Million |
| Earnings Before Tax Margin | 0.12 | 0.19 | 0.04 | 0.13 | 0.18 | 0.05 |
TSCDY
SMAWF
FSS
CRANESSOFT
BRFS
CX